A detailed history of Keebeck Alpha, LP transactions in Illumina, Inc. stock. As of the latest transaction made, Keebeck Alpha, LP holds 2,770 shares of ILMN stock, worth $334,255. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,770
Previous 2,308 20.02%
Holding current value
$334,255
Previous $220,000 19.55%
% of portfolio
0.39%
Previous 0.38%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$91.69 - $109.88 $42,360 - $50,764
462 Added 20.02%
2,770 $263,000
Q2 2025

Aug 08, 2025

SELL
$70.3 - $95.41 $164,783 - $223,641
-2,344 Reduced 50.39%
2,308 $220,000
Q1 2025

May 13, 2025

BUY
$79.34 - $144.22 $102,903 - $187,053
1,297 Added 38.66%
4,652 $369,000
Q4 2024

Feb 03, 2025

BUY
$128.99 - $155.15 $432,761 - $520,528
3,355 New
3,355 $448,000
Q1 2024

May 13, 2024

BUY
$127.73 - $147.2 $262,740 - $302,790
2,057 New
2,057 $282,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $19B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.